AI Analysis AI Analysis of CPRX
Powered by GPT-4o
New!
Stock Analysis PRO
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Evaluation of Catalyst Pharmaceuticals stock downgraded after the last trading session
(Updated on Jul 11, 2025)

Sell candidate since Jul 11, 2025

The Catalyst Pharmaceuticals stock price fell by -0.183% on the last day (Friday, 11th Jul 2025) from $21.85 to $21.81. During the last trading day the stock fluctuated 2.51% from a day low at $21.50 to a day high of $22.04. The price has fallen in 7 of the last 10 days and is down by -0.37% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -542 thousand shares and in total, 1 million shares were bought and sold for approximately $25.42 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.55% during the next 3 months and, with a 90% probability hold a price between $19.53 and $24.35 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

CPRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 08, 2025, and so far it has risen 5.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Catalyst Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $23.36. On a fall, the stock will find some support from the short-term average at $21.39. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock

Catalyst Pharmaceuticals finds support from accumulated volume at $21.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.540 between high and low, or 2.51%. For the last week, the stock has had daily average volatility of 3.18%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CPRX) For The Upcoming Trading Day Of Monday 14th

For the upcoming trading day on Monday, 14th we expect Catalyst Pharmaceuticals to open at $21.78, and during the day (based on 14 day Average True Range), to move between $21.45 and $22.17, which gives a possible trading interval of +/-$0.711 (+/-3.32%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $21.78 (0.14%) than the resistance at $22.76 (4.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Catalyst Pharmaceuticals stock A Buy?

Catalyst Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.634 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2025 - $21.78 ( 0.138%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*

CPRX Performance

Trading levels for CPRX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 22.32 2.34%
R2 22.11 1.39%
R1 21.99 0.81%
Price 21.81
S1 21.57 -1.08%
S2 21.45 -1.67%
S3 21.24 -2.61%

Accumulated Volume Support & Resistance Levels

Level Price
R3 24.96 14.44%
R2 24.29 11.37%
R1 22.76 4.36%
Price 21.81
S1 21.78 -0.138%
S2 21.70 -0.504%
S3 21.63 -0.85%

FAQ

What is the symbol for Catalyst Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Catalyst Pharmaceuticals is CPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.

What's the current price of Catalyst Pharmaceuticals Stock?
As of the end of day on the Jul 11, 2025, the price of an Catalyst Pharmaceuticals (CPRX) share was $21.81.

What is the 52-week high and low for Catalyst Pharmaceuticals Stock?
The 52-week high for Catalyst Pharmaceuticals Stock is $26.51 and the 52-week low is $15.34.

What is the market capitalization of Catalyst Pharmaceuticals Stock?
As of the Jul 11, 2025, the market capitalization of Catalyst Pharmaceuticals is 2.665B.

When is the next earnings date for Catalyst Pharmaceuticals?
The upcoming earnings date for Catalyst Pharmaceuticals is Aug 06, 2025.
Click to get the best stock tips daily for free!
ABOUT CATALYST PHARMACEUTICALS
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop...
GOLDEN STAR
Ticker Change Signal Date
RYTM
$62.29
39.19% Jun 25
NOV
$12.25
11.67% Jun 04
TENB
$32.20
1.13% Jun 02
G
GTM
$9.57
6.58% Jun 02
TAC
$8.90
28.20% May 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE